Truist maintains hold on Texas Instruments, keeps $195 target

Published 2025-02-05, 11:32 a/m
© Reuters.

On Wednesday, Truist Securities maintained its Hold rating on Texas Instruments shares (NASDAQ:TXN), with a consistent price target of $195.00. The firm’s analyst highlighted that there was no alteration to the capital management strategy following a minor adjustment in the company’s capital expenditure (capex) plan during the August capital management call. With a strong current ratio of 4.12 and liquid assets exceeding short-term obligations, Texas Instruments is well-positioned to maintain its commitment to a capital investment of approximately $5 billion annually through the first half of 2026 due to operational dependencies. InvestingPro data reveals the company operates with a moderate level of debt while maintaining a solid financial foundation.

The analyst pointed out that Texas Instruments is currently in a substantial multiyear investment cycle aimed at ensuring reliable and cost-effective capacity for its customers. This investment is particularly important for when market demand starts to rise, allowing the company to have more control over its supply chain. Despite the heavy investment phase, the company’s capex plan remains steady, with around $5 billion allocated for 2025, between $2 billion and $5 billion in 2026, and the expectation of increased spending flexibility in 2027 and beyond. The company’s strong financial position is evidenced by its $15.64 billion in revenue and impressive track record of maintaining dividend payments for 55 consecutive years.

Texas Instruments has been focusing on expanding its production capabilities, and management has reported that its various fab expansion projects are advancing successfully. The company has also expressed a positive outlook regarding unit growth in 2025 and believes it is improving its position in the datacenter end market.

The analyst’s reiteration of the Hold rating and the $195.00 price target indicates no change to their estimates or perspectives on Texas Instruments’ financial outlook. This stability in the company’s investment and operational plans suggests a steady approach to growth and capital management as it moves forward.

In other recent news, Texas Instruments has been the subject of several analyst notes. Citi maintained a Buy rating on the company with a target of $235, citing confidence in the company’s future performance and potential for analog inventory replenishment in 2025. Benchmark also reiterated a Buy rating, setting a target of $230, highlighting Texas Instruments’ high internal inventory levels as a strategic advantage.

Meanwhile, Stifel maintained a Hold rating on the company with a target of $200, noting a revenue beat primarily driven by the Personal Electronics sector. Stifel analysts also adjusted their forecast for Texas Instruments’ gross margins, expecting a drop due to lower utilization rates and a less favorable product mix.

Truist Securities adjusted the price target for Texas Instruments to $195, maintaining a Hold rating. The firm highlighted increased profitability challenges for the company due to lower factory utilization, consistent operating expenses, and reduced interest income. These are recent developments that investors should keep in mind.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.